BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 23726044)

  • 21. [Potential indications for helical tomotherapy in breast cancers].
    Lamberth F; Guilbert P; Gaillot-Petit N; Champagne C; Looten-Vieren L; Nguyen TD
    Cancer Radiother; 2014 Jan; 18(1):7-14. PubMed ID: 24314856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
    Schwartz DL; Hutcheson K; Barringer D; Tucker SL; Kies M; Holsinger FC; Ang KK; Morrison WH; Rosenthal DI; Garden AS; Dong L; Lewin JS
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1356-65. PubMed ID: 20646872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity-modulated whole pelvic radiotherapy provides effective dosimetric outcomes for cervical cancer treatment with lower toxicities.
    Lv Y; Wang F; Yang L; Sun G
    Cancer Radiother; 2014 Dec; 18(8):745-52. PubMed ID: 25451672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
    Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
    Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study.
    Naik A; Gurjar OP; Gupta KL; Singh K; Nag P; Bhandari V
    Cancer Radiother; 2016 Jul; 20(5):370-6. PubMed ID: 27368915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-volume analysis of radiation-induced trismus in head and neck cancer patients.
    Gebre-Medhin M; Haghanegi M; Robért L; Kjellén E; Nilsson P
    Acta Oncol; 2016 Nov; 55(11):1313-1317. PubMed ID: 27595312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
    Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
    Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated partial breast irradiation using robotic radiotherapy: a dosimetric comparison with tomotherapy and three-dimensional conformal radiotherapy.
    Rault E; Lacornerie T; Dang HP; Crop F; Lartigau E; Reynaert N; Pasquier D
    Radiat Oncol; 2016 Feb; 11():29. PubMed ID: 26919837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is IMAT the ultimate evolution of conformal radiotherapy? Dosimetric comparison of helical tomotherapy and volumetric modulated arc therapy for oropharyngeal cancer in a planning study.
    Servagi Vernat S; Ali D; Puyraveau M; Viard R; Lisbona A; Fenoglietto P; Bedos L; Makovicka L; Giraud P
    Phys Med; 2014 May; 30(3):280-5. PubMed ID: 23948367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for postoperative gastric cancer patients.
    Onal C; Dölek Y; Akkuş Yıldırım B
    Jpn J Radiol; 2018 Jan; 36(1):30-39. PubMed ID: 29101643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chest wall desmoid tumours treated with definitive radiotherapy: a plan comparison of 3D conformal radiotherapy, intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy.
    Liu J; Ng D; Lee J; Stalley P; Hong A
    Radiat Oncol; 2016 Mar; 11():34. PubMed ID: 26935470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
    Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiotherapy of hypopharynx cancers].
    Pointreau Y; Lafond C; Trémolières P; Legouté F; Servagi-Vernat S; Giraud P; Maingon P; Calais G; Lapeyre M
    Cancer Radiother; 2016 Sep; 20 Suppl():S126-30. PubMed ID: 27522185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin-sparing helical tomotherapy vs 3D-conformal radiotherapy for adjuvant breast radiotherapy: in vivo skin dosimetry study.
    Capelle L; Warkentin H; Mackenzie M; Joseph K; Gabos Z; Pervez N; Tankel K; Chafe S; Amanie J; Ghosh S; Parliament M; Abdulkarim B
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e583-90. PubMed ID: 22580119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
    Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy of primary cancers of the oropharynx and larynx, including the elective neck.
    van Dieren EB; Nowak PJ; Wijers OB; van Sörnsen de Koste JR; van der Est H; Binnekamp DP; Heijmen BJ; Levendag PC
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1299-309. PubMed ID: 10889384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intensity-modulated radiotherapy for head and neck cancer. Dose constraint for salivary gland and mandible].
    Pointreau Y; Lizée T; Bensadoun RJ; Boisselier P; Racadot S; Thariat J; Graff P
    Cancer Radiother; 2016 Oct; 20(6-7):445-51. PubMed ID: 27614524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [What technique for what tumor? Ethical and methodological issues: cervical cancer].
    Barillot I
    Cancer Radiother; 2014 Oct; 18(5-6):360-4. PubMed ID: 25179248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.